BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 24186955)

  • 1. A blood test for cerebrotendinous xanthomatosis with potential for disease detection in newborns.
    DeBarber AE; Luo J; Star-Weinstock M; Purkayastha S; Geraghty MT; Chiang JP; Merkens LS; Pappu AS; Steiner RD
    J Lipid Res; 2014 Jan; 55(1):146-54. PubMed ID: 24186955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A useful multi-analyte blood test for cerebrotendinous xanthomatosis.
    DeBarber AE; Luo J; Giugliani R; Souza CF; Chiang JP; Merkens LS; Pappu AS; Steiner RD
    Clin Biochem; 2014 Jun; 47(9):860-3. PubMed ID: 24769274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method.
    Bleyle L; Huidekoper HH; Vaz FM; Singh R; Steiner RD; DeBarber AE
    Mol Genet Metab Rep; 2016 Jun; 7():11-5. PubMed ID: 27331003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ESI-MS/MS quantification of 7alpha-hydroxy-4-cholesten-3-one facilitates rapid, convenient diagnostic testing for cerebrotendinous xanthomatosis.
    DeBarber AE; Connor WE; Pappu AS; Merkens LS; Steiner RD
    Clin Chim Acta; 2010 Jan; 411(1-2):43-8. PubMed ID: 19808031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward newborn screening of cerebrotendinous xanthomatosis: results of a biomarker research study using 32,000 newborn dried blood spots.
    Hong X; Daiker J; Sadilek M; DeBarber AE; Chiang J; Duan J; Bootsma AH; Huidekoper HH; Vaz FM; Gelb MH
    Genet Med; 2020 Oct; 22(10):1606-1612. PubMed ID: 32523054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn screening for cerebrotendinous xanthomatosis is the solution for early identification and treatment.
    DeBarber AE; Kalfon L; Fedida A; Fleisher Sheffer V; Ben Haroush S; Chasnyk N; Shuster Biton E; Mandel H; Jeffries K; Shinwell ES; Falik-Zaccai TC
    J Lipid Res; 2018 Nov; 59(11):2214-2222. PubMed ID: 30135217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A newborn screening method for cerebrotendinous xanthomatosis using bile alcohol glucuronides and metabolite ratios.
    Vaz FM; Bootsma AH; Kulik W; Verrips A; Wevers RA; Schielen PC; DeBarber AE; Huidekoper HH
    J Lipid Res; 2017 May; 58(5):1002-1007. PubMed ID: 28314860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for Cerebrotendinous Xanthomatosis: A retrospective biomarker study using both flow-injection and UPLC-MS/MS analysis in 20,000 newborns.
    Vaz FM; Jamal Y; Barto R; Gelb MH; DeBarber AE; Wevers RA; Nelen MR; Verrips A; Bootsma AH; Bouva MJ; Kleise N; van der Zee W; He T; Salomons GS; Huidekoper HH
    Clin Chim Acta; 2023 Jan; 539():170-174. PubMed ID: 36529270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis.
    DeBarber AE; Sandlers Y; Pappu AS; Merkens LS; Duell PB; Lear SR; Erickson SK; Steiner RD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(17-18):1384-92. PubMed ID: 21168372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on cerebrotendinous xanthomatosis.
    DeBarber AE; Duell PB
    Curr Opin Lipidol; 2021 Apr; 32(2):123-131. PubMed ID: 33630770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency.
    Pajares S; Arias A; García-Villoria J; Macías-Vidal J; Ros E; de las Heras J; Girós M; Coll MJ; Ribes A
    J Lipid Res; 2015 Oct; 56(10):1926-35. PubMed ID: 26239048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Laboratory diagnosis of a rare congenital neurodegenerative disease: cerebrotendinous xanthomatosis].
    Varga VE; Katkó M; Harangi J; Balogh I; Kapás I; Madar L; Seres I; Molnár MJ; Paragh G; Kovács GG; Harangi M
    Orv Hetil; 2014 May; 155(21):811-6. PubMed ID: 24836315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatotoxicity due to chenodeoxycholic acid supplementation in an infant with cerebrotendinous xanthomatosis: implications for treatment.
    Huidekoper HH; Vaz FM; Verrips A; Bosch AM
    Eur J Pediatr; 2016 Jan; 175(1):143-6. PubMed ID: 26156051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial variability of cerebrotendinous xanthomatosis lacking typical biochemical findings.
    Guenzel AJ; DeBarber A; Raymond K; Dhamija R
    JIMD Rep; 2021 May; 59(1):3-9. PubMed ID: 33977023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
    Honda A; Salen G; Matsuzaki Y; Batta AK; Xu G; Leitersdorf E; Tint GS; Erickson SK; Tanaka N; Shefer S
    J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monitoring of 7α-hydroxy-4-cholesten-3-one during therapy of cerebrotendinous xanthomatosis: a case report.
    Matysik S; Orsó E; Black A; Ahrens N; Schmitz G
    Chem Phys Lipids; 2011 Sep; 164(6):530-4. PubMed ID: 21679699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis.
    Mignarri A; Magni A; Del Puppo M; Gallus GN; Björkhem I; Federico A; Dotti MT
    J Inherit Metab Dis; 2016 Jan; 39(1):75-83. PubMed ID: 26153518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study.
    Stelten BML; Dotti MT; Verrips A; Elibol B; Falik-Zaccai TC; Hanman K; Mignarri A; Sithole B; Steiner RD; Verma S; Yahalom G; Zubarioglu T; Mochel F; Federico A
    Orphanet J Rare Dis; 2021 Aug; 16(1):353. PubMed ID: 34362411
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling in serum, cerebrospinal fluid, and brain of patients with cerebrotendinous xanthomatosis.
    Höflinger P; Hauser S; Yutuc E; Hengel H; Griffiths L; Radelfahr F; Howell OW; Wang Y; Connor SL; Duell PB; DeBarber AE; Martus P; Lütjohann D; Griffiths WJ; Schöls L
    J Lipid Res; 2021; 62():100078. PubMed ID: 33891937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
    Björkhem I; Hansson M
    Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.